Daewon Pharmaceutical financials at a glance
| Year | Year | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
₩0.00M | ₩47.27B | ₩60.06B | ₩74.36B | ₩90.66B | ₩115.93B | ₩144.70B | ₩138.87B | ₩138.17B | ₩158.88B | ₩181.98B | ₩216.19B | ₩240.72B | ₩265.46B | ₩286.65B | ₩317.83B | ₩308.50B | ₩354.18B | ₩478.88B | ₩526.95B | ₩0.00M |
| GM % | Gross Margin % |
|
0.00% | 64.30% | 64.71% | 65.66% | 64.18% | 60.02% | 59.24% | 54.81% | 51.66% | 52.73% | 54.36% | 53.52% | 56.47% | 56.65% | 57.13% | 56.13% | 53.21% | 49.28% | 49.25% | 48.42% | 0.00% |
| OM | Operating Margin |
|
0.00% | 13.77% | 14.13% | 12.24% | 12.19% | 11.45% | 15.13% | 9.64% | 9.75% | 9.78% | 9.78% | 10.55% | 12.11% | 9.49% | 10.67% | 11.00% | 7.77% | 5.45% | 8.96% | 6.12% | 0.00% |
| EPS | Earnings Per Share |
|
₩478.70 | ₩486.12 | ₩596.12 | ₩758.94 | ₩838.12 | ₩952.91 | ₩522.94 | ₩1.13k | ₩1.30k | ₩339.00 | ₩1.48k | ₩1.11k | ₩0.00 | ||||||||
| Div. | Dividends |
|
₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩0.00 | ₩117.36 | ₩161.18 | ₩166.01 | ₩226.61 | ₩233.40 | ₩240.41 | ₩0.00 | ₩200.00 | ₩200.00 | ₩350.00 | ₩0.00 |
| PR % | Payout Ratio % |
|
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15.46% | 19.23% | 17.42% | 43.33% | 20.59% | 18.45% | 0 | 59.00% | 13.52% | 31.53% | 0 |
| Sha. | Shares |
|
18.27m | 18.27m | 18.27m | 19.02m | 18.36m | 18.03m | 20.21m | 20.21m | 21.12m | 21.12m | 21.12m | 21.12m | 20.95m | 20.95m | 20.94m | 20.94m | 20.61m | 21.22m | 20.6m | 0m | 21.2m |
| OCF | Operating Cash Flow |
|
₩0.00M | ₩6.06B | ₩8.10B | ₩4.87B | ₩11.83B | ₩10.53B | ₩16.92B | ₩17.93B | ₩13.83B | ₩12.32B | ₩17.45B | ₩25.82B | ₩20.79B | ₩4.27B | ₩40.03B | ₩30.97B | ₩24.95B | ₩22.41B | ₩33.33B | ₩51.73B | ₩0.00M |
| FCF | Free Cash Flow |
|
₩0.00M | ₩2.97B | ₩5.40B | ₩2.09B | ₩4.58B | ₩1.36B | ₩9.99B | ₩7.78B | ₩10.52B | ₩2.47B | ₩4.40B | ₩6.01B | ₩10.92B | ₩5.80B | ₩-784.95M | ₩7.80B | ₩13.61B | ₩18.31B | ₩25.32B | ₩24.00B | ₩0.00M |
| FCFS | Free Cash Flow Per Share |
|
₩0.00 | ₩70.72 | ₩209.60 | ₩-57.97 | ₩135.23 | ₩-13.12 | ₩519.54 | ₩381.99 | ₩521.18 | ₩116.21 | ₩86.82 | ₩123.67 | ₩26.60 | ₩-659.90 | ₩-121.74 | ₩-271.26 | ₩461.60 | ₩504.57 | ₩943.39 | ₩1.48k | ₩0.00 |